[1]
T. Preveden, M. Ružić, and M. K. Pete, “The influence of hepatic steatosis on the success of antiviral therapy for chronic hepatitis C”, Vojnosanit Pregl, vol. 74, no. 4, pp. 317–322, Jun. 2017, doi: 10.2298/VSP150826190P.